Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9)

Alicia Villatoro; Vincent Cuminetti; Aurora Bernal; Carlos Torroja; Itziar Cossío; Alberto Benguría; Marc Ferré; Joanna Konieczny; Enrique Vázquez; Andrea Rubio; Peter Utnes; Almudena Tello; Xiaona You; Christopher G. Fenton; Ruth H. Paulssen; Jing Zhang; Fátima Sánchez-Cabo; Ana Dopazo; Anders Vik; Endre Anderssen; Andrés Hidalgo; Lorena Arranz

doi:10.1038/s41467-023-39601-3

Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9)

Alicia Villatoro
, Vincent Cuminetti
, Aurora Bernal
, Carlos Torroja
, Itziar Cossío
, Alberto Benguría
, Marc Ferré
, Joanna Konieczny
, Enrique Vázquez
, Andrea Rubio
, Peter Utnes
, Almudena Tello
, Xiaona You
, Christopher G. Fenton
, Ruth H. Paulssen
, Jing Zhang
, Fátima Sánchez-Cabo
, Ana Dopazo
, Anders Vik
, Endre Anderssen

Andrés Hidalgo, Lorena Arranz

Research output: Contribution to journal › Comment/debate

1 Scopus citations

Abstract

Correction to: Nature Communications, published online 03 January 2023 The original version of this Article omitted from the author list the 12^th author, Almudena Tello, who are from Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT – The Arctic University of Norway, MH2 building level 10, 9019 Tromsø, Norway. The corrected version of the Acknowledgements will remove the initials of A. Tello from the original version. Consequently, the initials of A.T was added to the Author Contributions as having ‘performed experiments’. The original version of this Article also contained an error in the labelling of the t-SNE plots from Figure 6a, which was inverted. This has now been corrected in both the PDF and HTML versions of the Article.

Original language	English
Article number	3874
Journal	Nature Communications
Volume	14
Issue number	1
DOIs	https://doi.org/10.1038/s41467-023-39601-3
State	Published - Dec 2023
Externally published	Yes

Access to Document

10.1038/s41467-023-39601-3

Cite this

Villatoro, A., Cuminetti, V., Bernal, A., Torroja, C., Cossío, I., Benguría, A., Ferré, M., Konieczny, J., Vázquez, E., Rubio, A., Utnes, P., Tello, A., You, X., Fenton, C. G., Paulssen, R. H., Zhang, J., Sánchez-Cabo, F., Dopazo, A., Vik, A., ... Arranz, L. (2023). Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9). Nature Communications, 14(1), Article 3874. https://doi.org/10.1038/s41467-023-39601-3

@article{9fa664eaa55b4f4996658c71c0a63911,

title = "Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9)",

abstract = "Correction to: Nature Communications, published online 03 January 2023 The original version of this Article omitted from the author list the 12th author, Almudena Tello, who are from Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT – The Arctic University of Norway, MH2 building level 10, 9019 Troms{\o}, Norway. The corrected version of the Acknowledgements will remove the initials of A. Tello from the original version. Consequently, the initials of A.T was added to the Author Contributions as having {\textquoteleft}performed experiments{\textquoteright}. The original version of this Article also contained an error in the labelling of the t-SNE plots from Figure 6a, which was inverted. This has now been corrected in both the PDF and HTML versions of the Article.",

author = "Alicia Villatoro and Vincent Cuminetti and Aurora Bernal and Carlos Torroja and Itziar Coss{\'i}o and Alberto Bengur{\'i}a and Marc Ferr{\'e} and Joanna Konieczny and Enrique V{\'a}zquez and Andrea Rubio and Peter Utnes and Almudena Tello and Xiaona You and Fenton, \{Christopher G.\} and Paulssen, \{Ruth H.\} and Jing Zhang and F{\'a}tima S{\'a}nchez-Cabo and Ana Dopazo and Anders Vik and Endre Anderssen and Andr{\'e}s Hidalgo and Lorena Arranz",

note = "Publisher Copyright: {\textcopyright} 2023, The Author(s).",

year = "2023",

month = dec,

doi = "10.1038/s41467-023-39601-3",

language = "English",

volume = "14",

journal = "Nature Communications",

issn = "2041-1723",

publisher = "Nature Research",

number = "1",

}

Villatoro, A, Cuminetti, V, Bernal, A, Torroja, C, Cossío, I, Benguría, A, Ferré, M, Konieczny, J, Vázquez, E, Rubio, A, Utnes, P, Tello, A, You, X, Fenton, CG, Paulssen, RH, Zhang, J, Sánchez-Cabo, F, Dopazo, A, Vik, A, Anderssen, E, Hidalgo, A & Arranz, L 2023, 'Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9)', Nature Communications, vol. 14, no. 1, 3874. https://doi.org/10.1038/s41467-023-39601-3

TY - JOUR

T1 - Author Correction

T2 - Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9)

AU - Villatoro, Alicia

AU - Cuminetti, Vincent

AU - Bernal, Aurora

AU - Torroja, Carlos

AU - Cossío, Itziar

AU - Benguría, Alberto

AU - Ferré, Marc

AU - Konieczny, Joanna

AU - Vázquez, Enrique

AU - Rubio, Andrea

AU - Utnes, Peter

AU - Tello, Almudena

AU - You, Xiaona

AU - Fenton, Christopher G.

AU - Paulssen, Ruth H.

AU - Zhang, Jing

AU - Sánchez-Cabo, Fátima

AU - Dopazo, Ana

AU - Vik, Anders

AU - Anderssen, Endre

AU - Hidalgo, Andrés

AU - Arranz, Lorena

PY - 2023/12

Y1 - 2023/12

N2 - Correction to: Nature Communications, published online 03 January 2023 The original version of this Article omitted from the author list the 12th author, Almudena Tello, who are from Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT – The Arctic University of Norway, MH2 building level 10, 9019 Tromsø, Norway. The corrected version of the Acknowledgements will remove the initials of A. Tello from the original version. Consequently, the initials of A.T was added to the Author Contributions as having ‘performed experiments’. The original version of this Article also contained an error in the labelling of the t-SNE plots from Figure 6a, which was inverted. This has now been corrected in both the PDF and HTML versions of the Article.

AB - Correction to: Nature Communications, published online 03 January 2023 The original version of this Article omitted from the author list the 12th author, Almudena Tello, who are from Stem Cells, Ageing and Cancer Research Group, Department of Medical Biology, Faculty of Health Sciences, UiT – The Arctic University of Norway, MH2 building level 10, 9019 Tromsø, Norway. The corrected version of the Acknowledgements will remove the initials of A. Tello from the original version. Consequently, the initials of A.T was added to the Author Contributions as having ‘performed experiments’. The original version of this Article also contained an error in the labelling of the t-SNE plots from Figure 6a, which was inverted. This has now been corrected in both the PDF and HTML versions of the Article.

UR - https://www.scopus.com/pages/publications/85163786353

U2 - 10.1038/s41467-023-39601-3

DO - 10.1038/s41467-023-39601-3

M3 - Comment/debate

C2 - 37391415

AN - SCOPUS:85163786353

SN - 2041-1723

VL - 14

JO - Nature Communications

JF - Nature Communications

IS - 1

M1 - 3874

ER -

Author Correction: Endogenous IL-1 receptor antagonist restricts healthy and malignant myeloproliferation (Nature Communications, (2023), 14, 1, (12), 10.1038/s41467-022-35700-9)

Abstract

Access to Document

Fingerprint

Cite this